» Articles » PMID: 9490794

Study of the Interaction of DNA with Cisplatin and Other Pd(II) and Pt(II) Complexes by Atomic Force Microscopy

Overview
Specialty Biochemistry
Date 1998 Apr 29
PMID 9490794
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Modifications in the structure of a 260 bp DNA (hlyM) fragment from Escherichia coli caused by interaction with Pd(II) and Pt(II) complexes were studied. Cisplatin and transplatin [cis- and trans-PtCl2(NH3)2 respectively], Pt2Cl2(Spym)4 (Spym = 2-mercaptopyrimidine anion), Pd-famotidine and Pt-famotidine were incubated with DNA for 24 h at 37 degrees C and then observed with an atomic force microscope. Atomic force microscopy (AFM) provides the opportunity for nanometer resolution in research on the interaction between nucleic acids and metal complexes. The complexes induced noticeable changes in DNA topography according to their different characteristics and structure. In the case of cisplatin a shortening in DNA strands was observed. Transplatin and Pt2Cl2(Spym)4 caused shortening and compaction, whilst an aggregation of two strands was observed for the Pt-famotidine compound but not for the Pd-famotidine compound or the metal-free famotidine.

Citing Articles

Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines.

Ko H, Chou H, Hou H, Kuo W, Liu W, Yen-Ping Kuo M J Dent Sci. 2025; 20(1):100-108.

PMID: 39873100 PMC: 11762581. DOI: 10.1016/j.jds.2024.09.018.


Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer.

Nicholson H, Sawers L, Clarke R, Hiom K, Ferguson M, Smith G Br J Cancer. 2022; 127(7):1340-1351.

PMID: 35778553 PMC: 9519926. DOI: 10.1038/s41416-022-01899-z.


Detection and Characterization of Single Cisplatin Adducts on DNA by Nanopore Sequencing.

Zhao X, Liu Y, Chen X, Mi Z, Li W, Wang P ACS Omega. 2021; 6(26):17027-17034.

PMID: 34250360 PMC: 8264939. DOI: 10.1021/acsomega.1c02106.


Why Concurrent CDDP and Radiotherapy Has Synergistic Antitumor Effects: A Review of In Vitro Experimental and Clinical-Based Studies.

Nagasawa S, Takahashi J, Suzuki G, Hideya Y, Yamada K Int J Mol Sci. 2021; 22(6).

PMID: 33808722 PMC: 8003508. DOI: 10.3390/ijms22063140.


Different Effects of Cisplatin and Transplatin on the Higher-Order Structure of DNA and Gene Expression.

Kishimoto T, Yoshikawa Y, Yoshikawa K, Komeda S Int J Mol Sci. 2019; 21(1).

PMID: 31861648 PMC: 6981875. DOI: 10.3390/ijms21010034.


References
1.
Rosenberg B, VANCAMP L, Trosko J, Mansour V . Platinum compounds: a new class of potent antitumour agents. Nature. 1969; 222(5191):385-6. DOI: 10.1038/222385a0. View

2.
Bustamante C, Rivetti C . Visualizing protein-nucleic acid interactions on a large scale with the scanning force microscope. Annu Rev Biophys Biomol Struct. 1996; 25:395-429. DOI: 10.1146/annurev.bb.25.060196.002143. View

3.
Mong S, Daskal Y, Prestayko A, Crooke S . DNA supercoiling, shortening, and induction of single-strand regions by cis-diamminedichloroplatinum(II). Cancer Res. 1981; 41(10):4020-6. View

4.
van der Veer J, den Hartog J, Lohman P, Reedijk J . Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry. 1985; 24(3):707-13. DOI: 10.1021/bi00324a025. View

5.
Sherman S, Gibson D, Wang A, Lippard S . X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))]. Science. 1985; 230(4724):412-7. DOI: 10.1126/science.4048939. View